ClinicalTrials.Veeva

Menu

Informatics Framework for Pulmonary Rehabilitation (CHIEF-PR)

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

COPD

Treatments

Behavioral: Best available care (BAC)
Behavioral: Telerehabilitation (TH)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03981783
R61HL143317-01 (U.S. NIH Grant/Contract)
GCO 18-1637

Details and patient eligibility

About

Previous studies clearly established clinical benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease however uptake and completion rate of pulmonary rehabilitation programs by these patients is limited by multiple barriers. The goal of this project to systematically evaluate impact of Comprehensive Health Informatics Engagement Framework for Pulmonary Rehabilitation (CHIEF-PR) in a randomized controlled trial. The main hypothesis is that CHIEF-PR will result in significantly higher rates of completion of a comprehensive pulmonary rehabilitation program.

Full description

Previous studies clearly established clinical benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) however uptake and completion rate of pulmonary rehabilitation (PR) programs by these patients is limited by multiple barriers. The study team developed a Comprehensive Health Informatics Engagement Framework for Pulmonary Rehabilitation which facilitates patient referral and promotes adherence with pulmonary rehabilitation program using innovative multi-pronged approach. It includes computer-mediated patient counseling to increase patient motivation in joining PR program followed by ongoing home-based support of PR by a telerehabilitation system that monitors patients' progress and allows remote oversight by clinical PR team. The goal of this project is to systematically evaluate impact of Comprehensive Health Informatics Engagement Framework for Pulmonary Rehabilitation (CHIEF-PR) in a randomized controlled trial. The study team's main hypothesis is that CHIEF-PR will result in significantly higher rates of completion of a comprehensive pulmonary rehabilitation program. The study team will enroll 120 COPD patients within 4 weeks of acute exacerbation of COPD into a randomized controlled trial and follow them for 12 months. Patients will be randomly assigned to intervention (CHIEF-PR) and control (best available standard of care) groups. Primary outcome will be completion rate of a comprehensive 3-month PR program. Secondary outcomes will include relevant clinical and patient-reported parameters.

Enrollment

120 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 40 years and older at the time of randomization;
  • Have a physician diagnosis of COPD
  • Have moderate to severe COPD according to GOLD classification (Stages II - III)
  • Understand spoken English or Spanish
  • Urgent care event due to COPD within 4 weeks of enrollment
  • Have no other member of the household enrolled in the study

Exclusion criteria

  • Evidence that the patient may move from the study area before the completion of the study
  • Impaired cognitive status as indicated by MMSE<24
  • Presence of any health condition, that would preclude participation (e.g., psychiatric diagnosis, unstable cardiovascular condition or physical disability)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Best available care (BAC)
Active Comparator group
Treatment:
Behavioral: Best available care (BAC)
Telerehabilitation (TH)
Experimental group
Treatment:
Behavioral: Telerehabilitation (TH)

Trial contacts and locations

1

Loading...

Central trial contact

Joseph Finkelstein, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems